Atlas Trials

Multi Center Clinical Study on the Lipid-lowering Efficacy and Safety of Menggongzi Tibetan Tea Special Drink

Clinical trial NCT06551298 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06551298
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Hyperlipidemias
Start date
2024-10-01
Primary completion
2025-08-08
Enrollment
129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.